Kenvue stock is down 28% in 2025 amid controversy surrounding its Tylenol brand, which is linked to autism when used during ...
Explore Kenvue Inc. (NYSE:KVUE) trends, dividends, and market activity among consumer stocks in S&P 500 today.
A potential legal headache for consumer healthcare giant Kenvue ( KVUE 8.36%) was causing pain for investors on Thursday.
Kenvue Inc. (NYSE: KVUE), spun out from Johnson & Johnson in 2023, is at a crossroads. As the world's largest pure-play ...
I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.
Kenvue urged U.S. regulators to deny a request warning against Tylenol’s use during pregnancy, laying out the most detailed ...
If you’re eyeing Kenvue stock and asking yourself what to do next, you’re definitely not alone. There has been more than a ...
Starboard Value CEO Jeff Smith said that he is "thrilled to own" Kenvue (NYSE:KVUE) even though the stock is down ~30% year ...